🔎 Trials Near Me

Home › Glioblastoma › Texas › San Antonio

Pag-aaral pangklinika para sa Glioblastoma sa San Antonio, TX

Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Antonio. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Nagre-recruitPhase 1/2
  • South Texas Accelerated Research Therapeutics (START), San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Nagre-recruitPhase 1/2
  • START | San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06914128

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3
  • University of Texas Health Mays Cancer Center, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Nagre-recruitPhase 2
  • The University of Texas Health Science Center at San Antonio, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305

Sacituzumab Govitecan in Recurrent Glioblastoma

Nagre-recruitPhase 2
  • University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT04559230

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Nagre-recruitPhase 2
  • Mays Cancer Center, UT Health San Antonio, San Antonio
Lahat ng edad · Lahat ng kasarian · Na-update Ago 27, 2025 · NCT04863950

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Nagre-recruitPhase 1
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2025 · NCT05460507

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Nagre-recruitPhase 1/2
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 26, 2025 · NCT01906385

Pag-aaral para sa Glioblastoma sa ibang lungsod

Iba pang pag-aaral sa San Antonio

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.